| Product Name | MF | CAS | Details |
|---|
| Ledipatasvir PVP | Details |
| Sitagliptin BASE | C16H15F6N5O | 486460-32-6 | Details |
| Finerenone intermediate | C6H8N2O | 95306-64-2 | Details |
| Sofosbuvir | C22H29FN3O9P | 1190307-88-0 | Details |
| Osimertinib Base | C28H33N7O2 | 1421373-65-0 | Details |
| Empagliflozin N-1 | C31H35ClO11 | 915095-99-7 | Details |
| L - carnosine | C9H14N4O3 | 305-84-0 | Details |
| Baloxavir | C24H19F2N3O4S | 1985605-59-1 | Details |
| Cortexolone Clascoterone Intermediate | C21H30O4 | 152-58-9 | Details |
| Paxlovid intermediates L-Valine,3-methyl-N-(trifluoroacetyl)-(9CI) | C8H12F3NO3 | 666832-71-9 | Details |
| Sitagliptin Phosphate Monohydrate | C16H18F6N5O5P | 654671-77-9 | Details |
| idebenone intermediates 6-(10-hydroxydecanoyl)-2,3-dimethoxy-5-methylphenol | C19H30O5 | 104966-97-4 | Details |
| 2-Ethoxy-1-Naphthoic Acid | C13H12O3 | 2224-00-2 | Details |
| Crizotinib | C21H22Cl2FN5O | 877399-52-5 | Details |
| Lenavatinib Mesylate | C21H19ClN4O4 | 417716-92-8 | Details |
| Ibrutinib AP | C25H24N6O2 | 936563-96-1 | Details |
| Apremilast API | C22H24N2O7S | 608141-41-9 | Details |
| Tenofovir Alafenamide Fumarate API | C25H33N6O9P | 1392275-56-7 | Details |
| NR-CL 70% | C11H15ClN2O5 | 23111-00-4 | Details |
| NADH | C21H30N7NaO14P2 | 606-68-8 | Details |
| TPP- Thiazole | C26H25BrNO2PS | 1352002-58-4 | Details |
| Tofacitinib intermediate 1 | C14H23ClN2 | 1062580-52-2 | Details |
| Sunitinib Malate | C26H33FN4O7 | 341031-54-7 | Details |
| Veliparib | C13H16N4O | 912444-00-9 | Details |
| Linagliptin intermediate 8-bromo-7-but-2-yn-1-yl-3-methyl-3,7-dihydro-1H-purine-2,6-dione | C10H9BrN4O2 | 666816-98-4 | Details |
| Trelagliptin succinate API | C22H26FN5O6 | 1029877-94-8 | Details |
| Trelagliptin intermediate 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-4-fluoro-benzonitrile | C13H9ClFN3O2 | 865759-24-6 | Details |
| Osimertinib N-2 | C25H31N7O | 1421372-66-8 | Details |
| 2-Aminobenzophenone | C13H11NO | 2835-77-0 | Details |
| Methotrexate | C20H22N8O5 | 59-05-2 | Details |
| Cefquinome Sulfate | C23H25N6O5S2.HO4S | 118443-89-3 | Details |
| Cetilistat API | C25H39NO3 | 282526-98-1 | Details |
| Alogliptin intermediate 2-Cyanobenzyl bromide | C8H6BrN | 22115-41-9 | Details |
| Clascoterone API | C24H34O5 | 19608-29-8 | Details |
| Declatasvir | C40H51ClN8O6 | 1009119-65-6 | Details |
| Palbociclib Intermediates | C13H13BrClN3O | 1016636-76-2 | Details |
| AP26113 intermediates 1 | C12H12Cl2N3OP | 1197953-49-3 | Details |
| Sacubitril intermediates | C23H27NO4 | 1012341-48-8 | Details |
| SAK-3 | C20H23N3O4 | 1256269-87-0 | Details |
| Pyrroloquinolinequinone disodium salt (PQQ) | C14H4N2Na2O8 | 122628-50-6 | Details |
| Lenalidomide | C13H13N3O3 | 191732-72-6 | Details |
| Linagliptin intermediate 3-Methyl-8-bromoxanthine(india site ) | C6H5BrN4O2 | 93703-24-3 | Details |
| Veliparib HCL | C13H16N4O | 912445-05-7 | Details |
| 5-Methyl-1H-tertazole | C2H4N4 | 4076-36-2 | Details |
| Brigatinib API | C29H39ClN7O2P | 1197953-54-0 | Details |
| Remdesivir Intermediate 2 4-amino-7-iodopyrrolo[2,1-f][1,2,4]triazine | C6H5IN4 | 1770840-43-1 | Details |
| Dasatinib monohydrate | C22H26ClN7O2S | 302962-49-8 | Details |
| Remdesivir Intermediate | C26H26O5 | 55094-52-5 | Details |
| Alogliptin intermediate 2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile | C13H10ClN3O2 | 865758-96-9 | Details |
| Ibrutinib N-1 | C22H22N6O | 1022150-12-4 | Details |
| Empagliflozin API | C23H27ClO7 | 864070-44-0 | Details |
| Trelagliptin intermediate 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]- | C18H20FN5O2 | 865759-25-7 | Details |
| Ceftiofur hydrochloride | C19H18ClN5O7S3 | 103980-44-5 | Details |
| Remdesivir Intermediate 2 PYRROLO[1,2-F][1,2,4]TRIAZIN-4-AMINE | C6H6N4 | 159326-68-8 | Details |
| Alogliptin Benzoate API | C25H27N5O4 | 850649-62-6 | Details |
| Finerenone intermediate | C7H9NO3 | 65193-87-5 | Details |
| Linagliptin intermediate (R)-(+)-3-tert-Butoxycarbonylaminopiperidine | C10H20N2O2 | 309956-78-3 | Details |
| Ibrutinib intermediates | C10H19NO3 | 143900-44-1 | Details |
| Palbociclib Intermediates | C14H22N4O2 | 571188-59-5 | Details |
| Hydroxy-phenyl-acetate2-(3,4-difluoro-phenyl)-cyclopropyl-ammonium | C17H17F2NO3 | 376608-71-8 | Details |
| Niraparib intermediates | C16H24N2O2 | 1171197-20-8 | Details |
| Dapagliflozin API | C24H33ClO8 | 960404-48-2 | Details |
| Baricitinib intermediate 2 | C7H10N2O2S | 1187595-85-2 | Details |
| Sacubitril intermediates (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid | C23H29NO4 | 1012341-50-2 | Details |
| β-Nicotinamide mononucleotide(NMN) | C11H15N2O8P | 1094-61-7 | Details |
| Alogliptin intermediate (R)-3-Piperidinamine dihydrochloride | C5H13ClN2 | 334618-23-4 | Details |
| 4-Hydroxypyridine | C5H5NO | 626-64-2 | Details |
| Baloxavir marboxil API | C27H23F2N3O7S | 1985606-14-1 | Details |
| Baricitinib N-1 | C22H27N7O4S | 1187595-90-9 | Details |
| Linagliptin intermediate 3-Methylxanthine( india site) | C6H6N4O2 | 1076-22-8 | Details |
| Sacubitril/Valsartan intermediates | C23H23O2P | 5717-37-3 | Details |
| Ceftiofur sodium | C19H18N5NaO7S3 | 104010-37-9 | Details |
| Sotorasib AMG510 | C30H30F2N6O3 | 2296729-00-3 | Details |
| Carboplatin | C6H12N2O4Pt | 41575-94-4 | Details |
| 3-ATMA | C10H10O4S | 61857-83-8 | Details |
| Lemborexant intermediates 1 5-Pyrimidinol, 2,4-dimethyl- (9CI) | C6H8N2O | 412003-95-3 | Details |
| Sitagliptin Phosphate | C16H15F6N5O.H3PO4 | 654671-78-0 | Details |
| 2-Hydroxy-1-naphthaldehyde | C11H8O2 | 708-06-5 | Details |
| Oxaliplatin | C8H12N2O4Pt | 63121-00-6 | Details |
| Linagliptin API | C25H28N8O2 | 668270-12-0 | Details |
| Linagliptin intermediate Quinazoline, 2-(chloromethyl)-4-methyl- | C10H9ClN2 | 109113-72-6 | Details |
| Baricitinib intermediate 1 | C13H23BN2O3 | 1029716-44-6 | Details |
| Linagliptin intermediate 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine | C20H17BrN6O2 | 853029-57-9 | Details |
| Dapagliflozin N-1 | C29H33ClO10 | 461432-25-7 | Details |
| Nicotine Intermediates Ethyl 6-amino-5-methoxyindole-2-carboxylate | C12H14N2O3 | 107575-60-0 | Details |
| Niraparib monohydrate API | C26H28N4O4S | 1613220-15-7 | Details |
| Lemborexant intermediates 2 | C20H21FO5S | 1450904-92-3 | Details |
| 2,2-Bis(p-acetoxyphenyl)-2H-1,4-benzoxazin-3(4H)-one | C24H19NO6 | 14008-48-1 | Details |
| Ibrutinib intermediates | C17H13N5O | 330786-24-8 | Details |
| Sacubitrial Calcium | C48H56CaN2O10 | 1369773-39-6 | Details |
| Sacubitril/Valsartan LCZ API | C48H58N6O8 | 936623-90-4 | Details |
| Tenofovir Alafenamide Fumarate N-3 | C15H18N5O4P | 379270-35-6 | Details |
| Lemborexant API | C22H20F2N4O2 | 1369764-02-2 | Details |
| Finerenone API | C21H22N4O3 | 1050477-31-0 | Details |
| Tofacitinib intermediate 2 | C6H3Cl2N3 | 90213-66-4 | Details |
| Cephapirin Benzathine | C33H37N5O6S2 | 97468-37-6 | Details |
| Abirterone Acetate | C26H33NO2 | 154229-18-2 | Details |
| Niraparib Base | C19H20N4O | 1038915-60-4 | Details |
| Baricitinib API | C16H17N7O2S | 1187594-09-7 | Details |
| Empagliflozin intermediates | C17H16BrClO2 | 915095-89-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||